RxSight (RXST) Net Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,335.00 |
| Dec 31, 2025 | 429.00 |
| Sep 30, 2025 | 269.00 |
| Jun 30, 2025 | -1,343.00 |
| Mar 31, 2025 | -7,500.00 |
| Dec 31, 2024 | 7,133.00 |
| Sep 30, 2024 | -52.00 |
| Jun 30, 2024 | 1,341.00 |
| Mar 31, 2024 | -16,874.00 |
| Dec 31, 2023 | 19,383.00 |
| Sep 30, 2023 | 1,041.00 |
| Jun 30, 2023 | 921.00 |
| Mar 31, 2023 | -39,342.00 |
| Dec 31, 2022 | 45,119.00 |
| Sep 30, 2022 | 1,397.00 |
| Jun 30, 2022 | 4,949.00 |
| Mar 31, 2022 | -1,005.00 |
| Dec 31, 2021 | 3,230.00 |
| Sep 30, 2021 | 5,618.00 |
| Jun 30, 2021 | -7,989.00 |
| Mar 31, 2021 | -15,943.00 |
| Dec 31, 2020 | -17,738.00 |
| Sep 30, 2020 | 76,894.00 |